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DIFFERENTIAL STIMULATION OF
MURINE LYMPHOMA GROWTH IN VITRO BY NORMAL AND
BCG-ACTIVATED MACROPHAGES
BY CARL F. NATHAN AND WILLIAM D. TERRY
(From theImmunology Branch, National Cancer Institute, National Institutes ofHealth,Bethesda,
Maryland 20014)
In vitro study of the interaction of macrophages with lymphocytes has led to
an abundance of reports in which macrophages are said to exert either stimula-
tory or inhibitory influences (1-4 ; additional references cited in 5) . In contrast,
the voluminous literature on the in vitro interaction of macrophages with
malignant cells describes only inhibitory effects, or none at all. That is, macro-
phages "activated" in a wide variety ofways appear to kill or inhibit the growth
of all malignant cells, but have little effect on nonmalignant cells ; while
"normal" macrophages appear to have only a slight inhibitory effect, if any, on
malignant cells (reviewed in 6 ; 7-10) .
If true, these generalizations would suggest : (a) that all malignant cells share
some property, not possessed by normal cells, such that their interaction with
activated macrophages leads to inhibition of their growth ; (b) that there are
only minor differences in the susceptibility of various types ofmalignant cells to
the activated macrophage ; and (c) that the acquisition by macrophages of
antitumor activity is a stereotypic, all-or-nothing response to potential activat-
ing agents .
The activation of murine macrophages by Bacille Calmette-Guerin (BCG)'
has been particularly well studied (11) . However, the interaction of macro-
phages from BCG-treated mice with malignant lymphoid cells has been studied
in vitro only rarely (12) . The lack ofmore intensive work in vitro with such cell
combinations is surprising, in view of the experimental use ofBCG in patients
with lymphoid malignancies (reviewed in 13), and the ability ofBCG to promote
resistance to the growth of lymphocytec leukemias or lymphomas in the mouse
(14-18) .
For these reasons, we have studied in detail the effects ofmacrophages from
BCG-treated and normal mice on a variety of murine lymphomas in vitro . The
results stand in contrast to previous generalizations concerning macrophage-
tumor cell interactions in vitro .
Materials and Methods
Mice .
￿
Female DBA/2, BALB/c, C57BL/6, and C3H/HeN mice age 2-6 wk were obtained from
the Jackson Laboratories (Bar Harbor, Maine) orNIH Animal Production .
'Abbreviations used in this paper: BCG, Bacille Calmette-Guerin ; 2-ME, 2-mercaptoethanol;
PPD, purified protein derivative .
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u.890 STIMULATION OF MURINE LYMPHOMAS BY MACROPHAGES
BCG.
￿
Phipps strain fresh frozen BCG (Trudeau Institute no . 1029, Saranac Lake, N . Y.) (9)
was stored at -70°C . Approximately 10' viable organisms in 0.1 ml were injected i.p . into DBA/2
mice unless otherwise indicated . Macrophages from mice injected with the vehicle [Middlebrook
7H9 broth (Difco Laboratories, Detroit, Mich .) with Tween 80 (Sigma Chemical Co ., St . Louis,
Mo .)] gave the same results as from uninfected mice ; the latter were routinely used as controls .
Tumors .
￿
Tumors were passed as ascites in the strainsindicated in Table I . The followingwere
obtained at the National Cancer Institute : L1210 from Mr . S. Yancey ; EL4, LSTRA from Dr . J.
Wunderlich ; P1534 IV a'/95 from Mr . N. Greenberg ; the L51784 subline of L5178Y from Mrs. H.
Porter ; and Line 10 hepatoma from Dr . B. Zbar . The latter was maintained only in tissue culture .
PU5-1, PU5-14, and PU5-45 were from DoctorsR. Asofsky and R. Tigelaar, NIAID. SL2 andTLX9
were the kind gift of Dr . J. Krahenbuhl, Palo Alto Medical Research Foundation . L929 cellswere
obtained from Microbiological Associates, Bethesda, Md .
Basic Assay.
￿
2-7 wk after BCG injection, injected and control mice were killed by cervical
dislocation . Two 4-cc aliquots ofcold Hank's balanced salt solution with 50U penicillin and 50 mg
streptomycin/100 ml were injected through the exposed peritoneum and withdrawn with a no . 25
needle, yielding 1-6 x 10 6 cellsper mouse, depending on age. Cellswere washed twice at 200g and
resuspended in RPMI 1640 (NIH Media Unit) made 20% in heat-inactivated fetal calf serum
(Grand Island Biological Co ., Grand Island, N.Y .) and 2 mM in glutamine, with antibiotics as
above ; pH was adjusted with 7.5%sodium bicarbonate("medium") . In cytocentrifuge preparations
(Sakura Fine Technical Co ., Ltd., Tokyo), theperitoneal cellsfrom both BCG-injected andnormal
mice appeared to contain approximately 40% macrophages ; the remainder were mostly lympho-
cytes . 5 x 10' cells in 0.2 cc medium were added to each well of flat-bottomed MicroTest plates
(Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) and placed in ahumidified 37°C incubator in 5%
C02 . After 3 h, nonadherent cellswere aspirated with a capillary pipette attached to wall suction,
and 0.2 cc medium wasadded, containing dilutions ofthrice-washedtumor cells, with or without 2-
mercaptoethanol (2-ME) (Sigma) . Each day, 0.04 cc of fresh medium was added, including 2-ME
where appropriate . [3H]Thymidine (Schwartz/Mann, Div . Becton, Dickinson& Co ., Orangeburg,
N . Y., spec act 3Ci/mmol or New England Nuclear, Boston, Mass ., spec act 20 or 2Ci/mmol) was
brought to a final spec act of 2Ci/mmol with cold thymidine (Sigma), and 0.02 cc containing 1 t Ci
in medium was added to each well for a 4-h pulse . These conditions were selected to make cpm a
linear function oflabeling time andoftumor cell number at high numbers, relationshipswhichdid
not obtain at higher specific activities . Wellswere aspirated onto glass fiber filters (Reeve-Angel,
Clifton, N. J .) with aMASH II harvester (Microbiological Associates), and washed copiously with
normal saline . Use of cold 5% trichloroacetic acid didnot affect results . Filter discs were punched
out with a 12-mm cork borer for liquid scintillation counting . For adherent target cells, the
labeling medium was discarded . 0.2 cc of 0.25% trypsin (Worthington Biochemicals, Freehold, N.
J .) in saline was added to each well for 20 min before harvesting as above . No visible target cells
and no cpm remained in the wells .
Long-Term Tumor Culture . Approximately 1 x 10 1 tumor cells from ascites passage were
seeded in 10 cc of medium in 250-ml flasks (Falcon) with or without 2-ME, monitored by daily
hemocytometer counts with 0.4% trypan blue, and passaged to maintain density at about 2-10 x
10'/ml .
Esterase Staining .
￿
Peritoneal cells adherent to 35-mm plastic dishes (Falcon) were stained for
nonspecific esterase as described (19) . With both BCG-injected and normal mice, adherent perito-
neal cells were 100% esterase positive (500-cell differentials) ; 1-3% were polymorphonuclear . The
adherent peritoneal cell population will be called "macrophages" .
Adherence .
￿
The percentage of peritoneal cells adhering to plastic wasdetermined by measur-
ingthe initialand residual adherent protein andDNA in saline-washed35-mmdishes as described
(20, 21) . Values forDNAandproteincontent per cell confirmed the previous report of Stubbs et al .
(22) . Finally, nonadherent cells in microtest wellswere countedby hemocytometer 3hafter adding
a known number of cells .
Glucose-l-"C Oxidation .
￿
Glucose carbon-1 oxidation by adherent peritoneal cells was meas-
ured as described previously (20), with and without the addition of approximately 2 x 10 6
polystyrene beads (Difco) per dish .
Results
Culture of Macrophages with L1210.
￿
During the first 4 h of culture, theCARL F. NATHAN AND WILLIAM D. TERRY
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FIG. la FIG. lb
FIG. 1.
￿
(a) [3Hlthymidine uptake by L1210 cells cultured alone or with normal or BCG
macrophages (mO) . Forcultures with macrophages, 5 x 10' peritoneal cells were added for 3
h, then nonadherent cells removed, before lymphoma target cells were added. Means
SEM are shown for the number ofexperiments indicated, each in triplicate. Results on day4
were similar to day 3. (b) Upper left panel : ['Hlthymidine uptake by 5 x 10' L1210 cells
cultured in varying concentrations of 2-ME in the absence of macrophages. Remaining
panels : varying numbers of L1210 cells cultured alone or with normal or BCG macrophages
(m(b) as in (a), butin the presence of 2 x 10-' M 2-ME .
amount of thymidine taken up by L1210 DBA/2 lymphoma cells was a linear
function of the number of lymphoma cells added, over the range 1 x 10' to 5 x
10" per well (Fig. 1 a). At this early time, there was no effect on thymidine
uptake when the lymphoma cells were cultured together with 5 x 10' (initial
number) adherent peritoneal cells from BCG-infected mice (called BCG macro-
phages) or from normal mice (called normal macrophages) .
By day 1 of culture, thymidine uptake by the lymphoma cells cultured alone
began to decrease (Fig. 1 a) . In the presence of normal macrophages, however,
thymidine uptake was markedly stimulated, both in comparison to L1210 cells
alone at the same time, and to L1210 cells in the presence of normal macro-
phages on the previous day. In contrast, very little stimulation of thymidine
uptake was seen in the presence of BCG macrophages.
On days 2, 3, and 4, these trends were accentuated, so that at the lower initial
target cell numbers, several hundred times as much thymidine was incorpo-
rated by L1210 cells in the presence of normal macrophages as in their absence,
before correcting for background. While BCG macrophages appeared markedly
cytostatic relative to normal macrophages, they exhibited no cytostatic effect892
￿
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when compared to the L1210 cells cultured alone . Similar results were obtained
when cultures were made in flat-bottomed Linbro plates (Linbro Co., New
Haven, Conn.) instead of microtest plates.
Tumors Behaving Like L1210 . Five additional lymphomas, passed in
DBA/2, BALB/c or C57B1/6 mice, gave results essentially the same as with
L1210. For brevity, only the data for the second day of culture are shown in
Table I, Group I. In addition, two lymphomas showed the same overall pattern
as with L1210, but the degree of stimulation of tumor cell thymidine uptake in
the presence of normal macrophages was less marked (Table I, Group 11).
Results like those described above were seen in 35 of 37 experiments done with
the lymphomas in Groups I and II. In the remaining two experiments, the BCG
macrophages were used more than 7 wk after BCG injection, and behaved like
normal macrophages.
When the initial tumor cell number was as high as 5 x 105, tumor cells often
appeared to exhaust the medium by day 1, so that thymidine uptake sometimes
fell below that on day 0. Thus, the range of tumor cell concentrations covered the
spectrum from what was detectable to what the medium could support.
Effect 42-ME .
￿
In 1973, Broome and Jeng reported that the growth of many
murine lymphomas in tissue culture is enhanced by the presence of certain
thiols, including 2-ME (23). Moreover, the "helper" effect of macrophages for
lymphocytes in several in vitro assays can be replaced wholly or in part by 2-ME
(24, 25) . We therefore examined the effects of 2-ME in the present assay . For
each tumor studied, the effect of 2-ME on thymidine incorporation by the tumor
cultured alone was examined in microtest plates on each day of culture, as
shown for L1210 in Fig. 1 b. For the eight lymphomas in Groups I and II, a
marked, dose-dependent stimulation of thymidine incorporation was evident
beginning on day 1 and peaking between day 2 and day 4 . For different
lymphomas, the optimal doses of 2-ME ranged from 6 x 10-6 to 2 x 10-4 M.
When an optimal dose of 2-ME was then added to cultures of L1210 alone or in
the presence of BCG macrophages or normal macrophages, the curves describ-
ing thymidine uptake vs. initial L1210 concentrations were made nearly identi-
cal, and were superimposable on those obtained in the absence of 2-ME but in
the presence of normal macrophages on the same day of culture (Fig. 1 b) . That
is, 2-ME appeared to substitute fully for the stimulatory effect of normal
macrophages on DNA synthesis by L1210 cells, and with the same time-course.
Very similar results with 2-ME were obtained for the other seven tumors listed
in Table 1, Groups I and II .
In parallel with the above studies, the same lymphomas were grown in 250-ml
flasks with and without 2-ME. The results of hemocytometer counts confirmed
and extended the observations of Broome and Jeng (23) . In general, the lympho-
mas whose thymidine incorporation was more markedly enhanced by normal
macrophages demonstrated greater enhancement of their replication in bulk
culture by 2-ME (Table II) .
Culture of Macrophages with L5178Y. Not all lymphomas demonstrated
stimulation of DNA synthesis by normal macrophages and by 2-ME . On the
contrary, two lymphomas and a suspension-culture cell line derived from the
Line 10 guinea pig hepatoma showed the same rapid rate of thymidine incorpora-CARL F. NATHAN AND WILLIAM D. TERRY
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TABLE II
Effect of2-ME on Lymphoma Cell Number in Bulk Culture
* Daily hemocytometer counts with trypan blue were done on lympho-
mas in 250-ml T flasks. The daily replication factor is the viable cell
counton dayn+1dividedby the viable counton dayn, adjusted forthe
dilution effect of passage, and averaged over all the days on which
there were surviving lymphoma cells in the culture lacking 2-ME,
which was at least 4 days. A daily replication factor less than 1 was
associated with all tumors that died out, even though there may have
been an initial period of growth. Medium was RPMI-1640 with 20%
FCS, glutamine, penicillin, and streptomycin .
$ 2 x 10-4 M.
tion whether or not macrophages were present, as shown for L5178Y in Fig. 2a.
2-ME had no effect on the thymidine uptake of L5178Y, with or without
macrophages (Fig. 2 b) . SL-2 and line 10 showed the same pattern (Table I,
Group III) . Results like those seen in Fig. 2 were seen in eight of eight
experiments with the tumors in Group III. 2-ME was also without effect on the
growth of these tumors in bulk tissue culture (Table II).
Correlation ofChanges in Thymidine Uptake and Target Cell Number.
￿
The
data suggested an unexpected stimulation of thymidine uptake of many mouse
lymphomas cultured with normal macrophages, but less so with BCG macro-
phages . Further studies were done to learn whether increased thymidine uptake
reflected increased lymphoma cell replication in the presence of macrophages,
and not macrophage replication in the presence of lymphoma cells. Hemocytome-
ter counts were done in parallel with [3H]thymidine pulsing of cultures of PU5-
14 plated alone or with normal or BCG macrophages . Because up to half the
macrophages became detached from the culture well by the second day, it was
necessary to distinguish floating macrophages from lymphoma cells . This was
accomplished by esterase staining of the nonadherent cell mixture. There was
extremely close correlation (regression coefficient = 0.996) over a wide range
(five orders of magnitude) between the numbers of nonadherent, esterase-
negative cells, and the thymidine uptake by the cultures . In contrast, the
Group Tumor
Daily
(A) without
2-ME
replication
(B) with
2-MET
factor*
B/A
I L1210 0.12 2.84 23.7
LSTRA 0.23 4.76 21.1
PU5-14 0.22 4.76 21.6
P1534 0.27 2.21 8.19
PU5-1 0.94 2.86 3.04
EL-4 1.73 4.39 2.54
II TLX-9 2.09 2.69 1.29
PU5-45 1.93 2.11 1.09
III L5178Y 3.37 4.01 1.19
SL-2 3.11 2.61 0.84894
a
10
104
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103
102
101
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￿
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￿
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FIG. 2a
￿
FIG. 2b
FIG. 2 . (a) [3H1thymidine uptake by L5178Y lymphoma cells cultured alone or with
normal or BCG macrophages (mO) as described in the legend of Fig. 1 . (b) Top panel :
[3Hlthymidine uptake by 5 x 103 L5178Y cells cultured in varying concentrations of 2-ME in
the absence of macrophages. Lower panels: varying numbers ofL5178Y cells cultured alone
or with normal or BCG macrophages (mr~) as in (a), butin thepresence of2 x 10-'M 2-ME.
number of nonadherent, esterase-positive cells was always less than the number
of peritoneal cells added initially, and was the same in wells with no appreciable
thymidine uptake (no lymphoma cells added) as in wells with low to high
thymidine uptake . This makes it exceedingly unlikely that macrophages were
replicating in the presence of lymphoma cells.
Effect of Peritoneal Lymphocytes.
￿
To rule out possible effects of small num-
bers of lymphocytes which might remain on the adherent macrophage mono-
layer, a comparison was made between the effects of unseparated, adherent, and
nonadherent peritoneal cells on the thymidine uptake of PU5-14 (Fig. 3). The
unseparated peritoneal cells showed the stimulation usually seen with normal
peritoneal macrophages, and relative lack of stimulation with BCG macro-
phages. All of this activity was present in the adherent peritoneal cell popula-
tion, and none of it in the nonadherent population. Thus it appears unlikely that
lymphocytes directly affected the results. These data do notrule out the possible
participation of adherent, esterase-positive, lymphoid cells.
Effect of Peritoneal Cell Dose and Culture Density.
￿
Because of the failure of
BCG macrophages to inhibit lymphoma cell growth at the concentrations tested,
the effect of increasing numbers of adherent peritoneal cells was examined. Fig.
4 indicates that even when confluent macrophage monolayers were employed,
ME Dose-response
~n (Day 1 ND)
4h
2 ME
Normal
M'P
Normal .10
BCG-M1,01
C. M"
No M1P No M~
Day 2 Day 3
Day 0 2 Exp Day 1 2 Exp
Normal M
BCG-MQ
No M~
No Ms
Normal MO
Day 2 2 Exp Day 3 1 Exp
BCG-M41
No M~
BCG-Mo
No Mo
Normal MIP Normal MOa
U
104
103
102
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ADHERENT PC
￿
TOTAL PC
￿
NONADHERENT PC
FIG. 3 .
￿
[3H]thymidine incorporation by various numbers of PU5-14 lymphoma cells cul-
tured alone for 2 days or with 5 x 10"peritoneal cells (PC) (middle panel), with theadherent
cells remaining after first adding 5 x 104 peritoneal cells for 3 h and then removing the
nonadherent cells (left panel), or with the nonadherent peritoneal cells removed from the
latter cultures (right panel) . Hemocytometer counts indicated that 41% of the normal and
46% of the BCG peritoneal cells were adherent.
and regardless of the initial number of lymphoma cells over a 50-fold range,
higher numbers of BCG macrophages continued to show a slight stimulatory
effect on thymidine incorporation by L1210 or P1534 . In contrast, increasing
numbers of normal macrophages resulted in a dramatic corresponding increase
in thymidine incorporation by the lymphoma cells.
Percent of Adherent Peritoneal Cells.
￿
Because of the steep dose-response
curve for the effect of normal macrophages on lymphoma cell thymidine incorpo-
ration, it was necessary to know whether the apparently greater stimulatory
effect of normal macrophages compared to BCG macrophages might be due
merely to the presence of more adherent cells in the normal peritoneal popula-
tion. This was ruled out as follows . The number of adherent cells was deter-
mined by assays for protein or for DNA content in 35-mm dishes, which were
used to achieve detectable levels, and compared to the value for the initial cell
inoculum. Alternatively, known numbers of peritoneal cells were added to
microtest dishes, the nonadherent cells counted by hemocytometer, and the
number of adherent cells calculated by difference. In six experiments, the mean
number of adherent cells was 43 .5% of those added for normal cells and 42.8% for
BCG cells.
Effect of Macrophages Contaminating the Ascites Tumor .
￿
The ascites tumor
could introduce a variable number of macrophages into the culture, raising the
question whether the different requirements of various tumors for 2-ME could896 STIMULATION OF MURINE LYMPHOMAS BY MACROPHAGES
EFFECT OF PC DOSE
PCX10 `
FIG. 4.
￿
Effect of the number of peritoneal cells (PC) added initially on the [3H)thymidine
uptake of P1534 or L1210 cells after 2 days in culture . 3 h after the addition of PC,
nonadherent cells were removed, and lymphoma cells added in the numbers indicated.
be explained by the number or nature of macrophages in the ascites. This
seemed extremelyunlikely since multiple passages ofthe tumors in vitro did not
diminish their 2-ME dependence nor independence, despite multiple dilution
and adherence steps which woulddeplete macrophages. For example, the macro-
phage content of PU5-14 ascites was 1.3% by esterase staining, but was 0% (500-
cell differential) after five passages in tissue culture; when both these PU5-14
populations were employed as targets in parallel experiments, the same marked
stimulation of thymidine uptake was seen in the presence of normal macro-
phages and the same minor degree of stimulation with BCG macrophages.
Considerations of dilution in these experiments would also mitigate against any
role of ascitic lymphocytes, unless they were rapidly replicating.
Effect of Different Doses and Routes of BCG Administration .
￿
To learn
whether a different manner of administering BCG might lead to macrophages
with a definite cytostatic effect, macrophages were obtained from mice given
BCG at the following times before harvest: 1 x 10' viable organisms i.p. at 2-7
wk; 1 x 10' i.p . at 2-7 weeks followed by 1 x 10' i.p. at 3 days; a single injectionCARL F. NATHAN AND WILLIAM D . TERRY
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of 1 x 10' i.p. at 3 days; 2.5 x 10' intravenously at 5 days [reported to produce
highly activated macrophages (26)1; and 1 x 10' i.p. at 2-7 wk followed by 2 .5 x
10' i.v. at 5 days. When tested on P1534, L1210, or LSTRA, the results showed
either the same minor degree of stimulation of lymphoma cell thymidine incorpo-
ration as with the first-listed treatment, or an even greater degree of stimula-
tion.
Macrophages from Mice of Different Strains .
￿
The results described using
DBA/2 mice were also seen with normal and BCG macrophages obtained from
C3H/HeN, BALB/c, or C57BL/6 mice, tested on various tumors in both Group I
and Group III .
Demonstration of Activation of BCG Macrophages.
￿
That the BCG macro-
phages used in this study were in fact "activated" was shown by morphologic,
biochemical, and functional criteria. First, inspection under phase-contrast
microscopy revealed that about 50% of the BCG macrophages were flattened
(phase-dark) after 1/2 h ofculture, while almost none of the normal macrophages
were flattened at that time (26).
Second, in two experiments, glucose carbon-1 oxidation to COz by resting
macrophages averaged 21 nmol/mg-cell protein-hour for BCG cells compared to 9
for normal cells . During latex phagocytosis, values increased to 152 for BCG
cells compared to 51 for normal cells.
Third, normal and BCG macrophages were cultured with L929 cells, an
adherent murine fibroblast line. In contrast to the results seen with lymphoma
targets, BCG macrophages caused definite inhibition of thymidine uptake by
residual adherent L929 cells after 2 days in culture, whether compared to
normal macrophages or compared to L929 cells alone . The mean results from six
experiments, each in triplicate, were: 5,391 ± 429 cpm for 5 x 10' L929 cells
alone, 7,989 ± 1,049 cpm in the presence of normal macrophages, and 2,005 -
201 cpm in the presence of BCG macrophages . The minor degree of stimulation
caused by normal macrophages could not be duplicated by adding 2-ME. In fact,
2-ME was toxic to L929 cells at all concentrations tested, from 2 x 10-6 M to 2 x
10-3 M .
Discussion
The data presented here unexpectedly revealed that the DNA synthesis of
many (though not all) murine lymphomas was markedly stimulated in vitro by
normal mouse peritoneal macrophages. Equally unexpected was the finding
that macrophages from BCG-infected mice were not inhibitory to any of the 10
lymphomas tested; they were simply much less stimulatory than normal macro-
phages. This was not due to any major deficiency in the degree of activation of
the BCG macrophages, because they were able to inhibit the thymidine uptake
of an adherent fibroblast target cell line (L929), as has been described by others
using macrophages activated in the same (9) or different ways (27-30) . That the
BCG macrophages were activated was also supported by their enhanced degree
of glucose carbon-1 oxidation compared to normal macrophages, both at rest and
with phagocytosis, as has been shown previously with guinea pig (20, 31) or
human (32) mononuclear phagocytes incubated in media rich in migration
inhibitory factor, or by infection of mice with BCG (33) or Listeria monocyto-
genes (33, 22).898
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Stimulation of lymphoma cell DNA synthesis by normal macrophages was
only evident with lymphoma lines which could also be stimulated by 2-ME, both
in microculture and in bulk culture (23) . The stimulation by normal macro-
phages and by 2-ME were both dose-dependent, and they had the same time-
course . Addition of optimal doses of 2-ME to the lymphoma cell cultures over-
came the relative lack of stimulation offered by BCG macrophages, but was not
additive to that provided by normal macrophages. The degree of stimulation
attainable with normal macrophages and with 2-ME were correlated for eight
different lymphomas. On the other hand, two lymphomas and one xenogeneic
suspension-culture hepatoma were unaffected in their growth or thymidine
uptake by normal macrophages or by 2-ME . No stimulatory effect on ME-
dependent lymphoma cells was seen when peritoneal lymphocytes, ME-inde-
pendent lymphoma cells, L929 fibroblasts, or Line 10 hepatoma cells were
substituted for normal macrophages (unpublished observations) .
The effects described above were independent of the H-2 haplotype of the
tumors and macrophages . It also did not appear to matter whether the tumors
bear the theta antigen (EL4 (34), PU5-14 2, PU5-452), surface immunoglobulin
(PU5-12), the EA receptor [LSTRA (35)], or none of these [L1210 (34)] . The
stimulatory cell appeared to be the peritoneal macrophage, not the lymphocyte,
and stimulation by macrophages or by 2-ME appeared to be unrelated to the
small number ofmacrophages or lymphocytes present in the lymphoma ascites .
Evans and Alexander (12) previously described cultivation ofTLX9 and SL2
lymphoma cells with macrophagesfrom BCG-treated DBA/2 mice . Using lyophi-
lized BCG, they observed no effect on the lymphomas unless purified protein
derivative (PPD) was first added to the BCG macrophages . In that case, there
appeared to be in cytostasis compared to the lymphoma grown in the
presence ofnormal macrophages. Comparison to the lymphoma cultured alone
was not given . Effects on the lymphoma were followed with hemocytometer
counts . We find the latter a difficult assay to interpret, since as many as half the
macrophages may become nonadherent during culture. Using TLX9, we find
that the addition ofPPD at 1 or 10 Ag/ml for the first 4 or 48 h of culture reduces
the slight degree ofstimulation seen with BCG macrophages, but in ourhands it
has not produced significant cytostasis compared to TLX9 cultured alone, as
judged by tritiated thymidine uptake . In addition, PPD itselfseemed to exert a
toxic effect on the tumor (unpublished observations) .
Olivotto and Bomford previously noted a slight increase in thymidine uptake
by RI leukemia cells in the presence ofnormal mouse macrophages (36) . Namba
and Hanaoka reported that contaminatingphagocytic cells appeared to enhance
the growth in vitro of an explanted mouse myeloma (37) . Stimulation of L1210
cell thymidine uptake in the presence of normal DBA/2 macrophages has also
been observed by others .'
In contrast, the great majority of earlier workers have not reported stimula-
tion of the growth of murine lymphomas or leukemias when cultured with
normal macrophages, and have observed cytotoxic or cytostasic effects when the
s Agofsky, R. Personal communication . While PU5-14 originally consisted mostly of surface
immunoglobulin-positive cells, the explant from which our ascites line was established contained
mainly 0-positive cells .
a Papermaster, B. W. Personal communication .lymphomas were cultured with macrophages activated in ways other than BCG
infection of the donor. Such means of activation have included use of lymphoma
cells or skin grafting to immunize the donor of macrophages or the donor of
lymphocytes cultured with the macrophages (38-44), use of macrophages from
tumor-bearing mice (45), treatment of macrophages in vitro with double-
stranded RNA or endotoxin (46), and infection of the macrophage donor with
protozoa (30) or heat-killed Corynebacterium parvum (36).
It is of interest that most of the lymphoma lines used previously for in vitro
studies with macrophages appear in retrospect to belong to the groups which in
our hands are stimulated very little or not at all by normal macrophages nor by
2-ME . Very likely this reflects the tendency to select for in vitro studies those
tumors which grow well when cultured alone. Such a selection artefact may
explain why results such as those reported here have not been more widely
described. In addition, stimulation of DNA synthesis would not be detected by
assays using prelabeled target cells.
Previous generalizations concerning macrophage-tumor cell interactions in
vitro (6) would appear to be circumscribed not only by the results reported here,
but also by previous work showing the ability of macrophages to kill, or inhibit
the proliferation of, a variety of nonmalignant cells, including fibroblasts (29,
47-49), erythrocytes (50), and even macrophages (29, 51).
Thus, the patterns of macrophage-target cell interaction in vitro appear to be
highly dependent on the stimuli to which the macrophages are subjected, the
target cells studied and the assays employed. Such patterns range all the way
from profound cytotoxicity to equally intense stimulation.
The implications of the present studies for macrophage-tumor interaction in
vivo are not clear. There is essentially no information about the biochemistry of
the stimulation of lymphoma cell growth by normal macrophages or by 2-ME or
the reason for the lack of stimulation by BCG-activated macrophages. Increased
understanding of this system may shed light on the interactions between
macrophages and normal lymphocytes.
Summary
Peritoneal macrophages from mice infected with Bacille Calmette-Guerin
(BCG) and from normal mice were examined for their effects in vitro on
thymidine uptake by 10 murine lymphomas, a murine fibroblast line, and a
guinea pig hepatoma. Only the murine fibroblast line showed growth inhibition
in the presence of BCG macrophages. For the majority of tumors, normal
macrophages were profoundly stimulatory to tumor cell DNA synthesis, while
BCG macrophages were much less stimulatory, without being frankly inhibi-
tory. The effect of 2-mercaptoethanol on tumor cell growth was also studied. All
lymphomas stimulated to grow more rapidly in vitro by normal macrophages
were stimulated to a similar degree by 2-mercaptoethanol.
The authors are grateful to Ms. Virginia Hill for expert technical assistance, to Mssrs. Walter
Lyles and Francis Jones for animal care, and to Mrs. Marilyn Schoenfelder for preparation of the
manuscript.
Received forpublication 15 May 1975 .
CARL F. NATHAN AND WILLIAM D. TERRY
￿
899900
￿
STIMULATION OF MURINE LYMPHOMAS BY MACROPHAGES
Bibliography
1 . Hoffman, M ., and R . W . Dutton . 1971 . Immune response restoration with macro-
phage culture supernatants . Science (Wash . D.C .) . 172 :1047 .
2 . Wood, D . D ., and S . L. Gaul . 1974 . Enhancement of the humoral response of T-cell
depleted murine spleens by a factor derived from human monocytes in vitro . J .
Immunol . 113 :925 .
3 . Calderon, J ., and E . R . Unanue . 1975 . Two biological activities regulating cell
proliferation found in cultures of peritoneal exudate cells . Nature (Lond .) . 253 :359 .
4 . Peter, E ., and M . Feldmann . 1975 . Role of macrophages in in vitro induction of T-
helper cells . Nature (Loud.) . 254 :352 .
5 . Keller, R . 1975 . Major changes in lymphocyte proliferation evoked by activated
macrophages . Cell . Immunol . 17:542 .
6 . Hibbs, J . B ., Jr . 1974. Discrimination between neoplastic and non-neoplastic cells in
vitro by activated macrophages . J . Natl . Canc . Inst . 53 :1487 .
7 . Holtermann, O . A ., E . Klein, and G . P . Casale . 1973 . Selectiv e cytotoxicity of
peritoneal leukocytes for neoplastic cells . Cell . Immunol . 9 :339 .
8 . Basic, I ., L . Milas, D . J . Grdina, and H . R . Withers . 1974 . Destruction of hamster
ovarian cell cultures by peritoneal macrophages from mice treated with Corynebacte-
rium granulosum . J . Natl . Canc . Inst . 52 :1839 .
9 . Cleveland, R. P., M . S . Meltzer, and B . Zbar . 1974 . Tumor cytotoxicity in vitro by
macrophages from mice infected with Mycobacterium bovis strain BCG . J . Natl .
Canc . Inst . 52:1887 .
10 . Piessens, W . F ., W . H . Churchill, Jr ., and J . David . 1975 . Macrophages activated in
vitro with lymphocyte mediators kill neoplastic but not normal cells . J . Immunol .
114:293 .
11 . Mackaness, G . B . 1970 . The mechanism of macrophage activation . In Infectious
Agents and Host Reactions . Stuart Mudd, editor . W . B . Saunders Co ., Philadelphia .
61 .
12 . Evans, R ., and P . Alexander . 1972 . Mechanism of immunologically specific killing of
tumor cells by macrophages . Nature (Lond .) . 236:168 .
13 . Bast, R . C ., Jr ., B . Zbar, T . Borsos, and H . J . Rapp . 1974 . BCG and cancer (second of
two parts) . N . Engl . J . Med . 290:1458 .
14 . Lemonde, P . and M . Clode . 1962 . Effect ofBCG infection on leukemia and polyoma in
mice and hamsters . Proc . Soc . Exp . Biol . Med. 111 :739 .
15 . Ariel, J . 1967 . Immunotherapie active non specifique par le B.C .G . de la leucemie
virale E d G2 chex des receveurs isogeniques . Rev . Franc . Etud . Clin . Biol . 12:912 .
16 . Mathe, G ., P . Pouillart, and F . Lapeyraque . 1969 . Active immunotherapy of L1210
leukemia applied after the graft of tumor cells . Br . J . Cancer 23 :814 .
17 . Parr, I . 1972 . Response of syngeneic murine lymphomata to immunotherapy in
relation to antigenicity of the tumor . Br . J . Canc . 26 :174 .
18 . Pearson, J .W ., G . R . Pearson,W . Gibson, J . C . Chermann, and M . A . Chirigos. 1972 .
Combined chemoimmunstimulation therapy against murine leukemia . Cancer Res .
32:904 .
19 . Yam, L . T ., C . Y . Li, W . H . Crosby . 1971 . Cytochemica l identification of monocytes
and granulocytes. Am . J . Clin . Pathol . 55 :283 .
20 . Nathan, C . F ., M . L . Karnovsky, and J . R . David . 1971 . Alterations of macrophage
functions by mediators from lymphocytes . J . Exp . Med. 133:1356 .
21 . Kissane, J . M ., and E . Robins . 1958 . The fluorometric measurement of deoxyribonu-
cleic acid in animal tissues with special reference to the central nervous system . J .
Biol . Chem . 233 :184 .
22 . Stubbs, M ., A . V . Kiihner, E . A . Glass, J . R . David, and M . L . Karnovsky . 1973 .CARL F . NATHAN AND WILLIAM D . TERRY
￿
90 1
Metabolic and functional studies on activated mouse macrophages . J . Exp . Med .
137:537 .
23 . Broome, J . D ., and M . W . Jeng . 1973 . Promotion of replication in lymphoid cells by
specific thiols and disulfides in vitro . J . Exp . Med . 138:574 .
24 . Click, R . E ., L . Benck, and B . J . Alter . 1972 . Enhancemen t of antibody synthesis in
vitro by mercaptoethanol . Cell Immunol . 3:264 .
25 . Bevan, M . J ., R . Epstein, and M . Cohn . 1974 . The effect of 2-mercaptoethanol on
murine mixed lymphocyte cultures . J . Exp . Med . 139:1025 .
26 . Blanden, R . V ., M . J . Lef1'ord, and G . B . Mackaness . 1969 . The host response to
Calmette-Guerin bacillus infection in mice . J . Exp . Med . 129:1079 .
27 . Hibbs, J . B ., Jr ., H . Lewis, J . Lambert, Jr., and S . Remington . 1972 . Control of
carcinogenesis : a possible role for the activated macrophage . Science (Wash . D.C .) .
177:998 .
28 . Hibbs, J . B ., Jr ., L . H . Lambert, Jr ., and J . S . Remington . 1972 . Possible role of
macrophage mediated nonspecific cytotoxicity in tumor resistance . Nat . New Biol .
235 :48 .
29 . Granger, G . A ., and R . S . Weiser . 1964 . Homograft target cells : specific destruction in
vitro by contact interaction with immune macrophages . Science (Wash . D.C .) .
145 :1427 .
30 . Krahenbuhl, J . L ., and J . S . Remington . 1974 . The role of activated macrophages in
specific and nonspecific cytostasis of tumor cells . J . Immunol . 113 :507 .
31 . Nathan, C . F ., H . G . Remold, and J . R . David . 1973 . Characterization of a lympho-
cyte factor which alters macrophage functions . J . Exp . Med . 137:275 .
32 . Rocklin, R . E ., C . T . Winston, and J . R . David . 1974 . Activation of human blood
monocytes by products of sensitized lymphocytes . J . Clin . Invest . 53:559 .
33 . Ratzan, K . R ., D . M . Musher, G . T . Keusch, and L . Weinstein . 1972 . Correlation of
increased metabolic activity, resistance to infection, enhanced phagocytosis, and
inhibition ofbacterial growth by macrophages from Listeria- and BCG-infected mice .
Infect . Immunol . 5 :499 .
34 . Shevach, E . M ., J . D . Stobo, and 1 . Green . 1972 . Immunoglobulin and B-bearing
murine leukemias and lymphomas . J . Immunol . 108:1146 .
35 . Shevach, R ., R. Herberman, R . Lieberman, M . M . Frank, and I . Green . 1972 .
Receptors for immunoglobulin and complement on mouse leukemias and lympho-
mas . J . Immunol . 108:325 .
36 . Olivotto, M ., and R . Bomford . 1974 . In vitro inhibition of tumour cell growth and
DNA synthesis by peritoneal and lung macrophages from mice injected with Coryne-
bacterium parvum . Int . J . Cancer 13:478 .
37 . Namba, Y ., andM . Hanaoka . 1972 . Immunocytology of cultured IgM-forming cells of
mouse . I . Requirement of phagocytic cell factor for the growth ofIgM-forming tumor
cells in tissue culture . J . Immunol . 109 :1193 .
38 . Weaver, J . M . 1958 . Destruction of mouse ascites tumour cells in vivo and in vitro by
homologous macrophages, lymphocytes and cell free antibodies . Proc . Am . Assoc .
Cancer Res . 2 :354 .
39 . Evans, R ., and P . Alexander. 1970 . Cooperation of immune lymphoid cells with
macrophages in tumor immunity . Nature (Lond .) . 228:620 .
40 . Grant, C . K ., G . A . Currie, and P. Alexander . 1970 . Thymocytes from mice immu-
nized against an allograft render bone marrow cells specifically cytotoxic . J . Exp .
Med . 135:150 .
41 . Lohmann-Matthes,M.-L., F . G . Ziegler, and H . Fischer . 1973 . Macrophage cytotoxic-
ity factor . A product ofin vitro sensitized thymus-dependent cells .Eur . J . Immunol .
3 :56 .
42 . Zembala, M ., W . Ptak, and M . Hanczakowska . 1973 . The role of macrophages in the902
￿
STIMULATION OF MURINE LYMPHOMAS BY MACROPHAGES
cytotoxic killing of tumor cells in vitro. I. Primary immunization of lymphocytes in
vitro for target cell killing and the mechanism of lymphocyte-macrophage coopera-
tion. Immunology. 25:631.
43. Zighelboim, J ., B. Bonavida, and J. L. Fahey. 1974. Heterogenous populations of
cytotoxic cells in the peritoneal cavity of BALB/c mice immunized with allogeneic
EL4 leukemia cells. Cell Immunol . 12:280.
44. Dimitriu, A., M . Dy, N. Thomson, and J. Hamburger. 1975 . Macrophage cytotoxicity
in the mouse immune response against a skin allograft. J . Immunol. 114 :195 .
45. Kirchner, H., A. V. Muchmore, T. M. Chused, H. T. Holden, and R. B. Herberman.
1975. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor
cells from spleens of tumor-bearing mice. J. Immunol . 114 :206.
46. Alexander, P. and R. Evans. 1971 . Endotoxin and double-stranded RNA render
macrophages cytotoxic. Nat. New Biol. 232:76 .
47. Kramer, J. J ., and G. A. Granger. 1972. The in vitro induction and release of a cell
toxin by immune C57BL/6 mouse peritoneal macrophages. Cell. Immunol. 3:88 .
48. McLaughlin, J . F., N. H. Ruddle, and B. H . Waksman. Relationship between
activation of peritoneal cells and their cytopathogenicity . RES J. Reticuloendothel .
Soc . 12 :293 .
49. Keller, R. 1974. Modulation of cell proliferation by macrophages: a possible function
apart from cytotoxic tumor rejection. Br. J . Cancer 30 :401.
50. Melson, H., and R. Seljelid. 1973. The cytotoxic effect of mouse macrophages on
syngeneic and allogeneic erythrocytes. J. Exp . Med . 137:807 .
51. Gallily, R. 1975. Allogeneic recognition and killing capacity ofimmune macrophages
in mixed macrophage cultures (MMC. Cell. Immunol. 15 :419.